Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Gets Social, But Not Too Social

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA is trying multiple channels in social media to communicate drug safety information, but its two-way communication capacity is lower than many would like.

You may also be interested in...



Pharma Companies Starting To Build Dedicated Digital Marketing/Social Media Staffs

Despite an uncertain regulatory environment and no clear way to link digital marketing and social media activities to revenues, pharmaceutical companies are starting to spend more on promotional activities in the digital realm compared to traditional media (TV/radio/print advertising) and are building dedicated staffs to support these activities.

FDA’s Social Media Guidance: As Industry Waits, How Watchful Should It Be?

In the absence of clear policy from the agency, GSK keeps careful eyes on Facebook, but experts disagree on the extent to which drug companies are required to actively monitor social media sites.

FDA Tracking Tweets, Blog Posts To Gauge Reach Of Drug Safety Communications

FDA is in the early stages of developing a plan for how to get the most dissemination bang for its risk communication bucks.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS074359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel